Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption. - Wikidata - awgldk - TriplyDB

Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption.

Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption.

http://www.wikidata.org/entity/Q37961823

about

Vitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequences The patients' perspective of international normalized ratio self-testing, remote communication of test results and confidence to move to self-management.Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression.Anticoagulant use in real time.Pharmacoeconomic implications of thromboprophylaxis with new oral anticoagulants after total hip or knee replacement in the USA.The changing face of anticoagulation management: an improving countenance.The future landscape of anticoagulation management.INR Stability, Clinical Importance, and Predictors in Patients With Atrial Fibrillation and Venous Thromboembolism Receiving Vitamin K Antagonists.

P2860

Q26746062-A82972AB-B54A-4C69-91A3-FF6F8C98FE3D Q30151320-6A2D3008-3114-4B29-A381-01864CAF1DAF Q33891646-1B666E2A-11B1-48CA-9826-14ED96E1BE54 Q38062284-1EA7E270-D4FA-4739-9BCF-DDC7C42E977D Q38084401-40DB09B9-BAE9-4FDA-B53E-A31FC22BF35F Q44292305-F3EA8375-042C-46F0-963B-BA9C53DC2D71 Q44797330-30ECD8AA-A91F-4C32-8287-E87D13E910A6 Q55209378-E005C66D-15EB-4C87-8330-9ACA382613C9

P2860

Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption.

http://www.wikidata.org/entity/Q37961823

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Anticoagulation patient self-m ...... or clinical practice adoption.

@en

Anticoagulation patient self-m ...... or clinical practice adoption.

@nl

type

label

Anticoagulation patient self-m ...... or clinical practice adoption.

@en

Anticoagulation patient self-m ...... or clinical practice adoption.

@nl

prefLabel

Anticoagulation patient self-m ...... or clinical practice adoption.

@en

Anticoagulation patient self-m ...... or clinical practice adoption.

@nl

P1433

Q37961823-266F0AED-ACA8-4466-87DE-265354BC324A

P1476

Q37961823-35AC0BD2-79A0-434C-9DA8-4E49F03BD7B3

P2093

Q37961823-B68FEDD8-1113-49FE-93F4-ABD783128BD7

Q37961823-BF21D1BF-0AE5-487C-AC03-EA985B82010B

Q37961823-D86E1129-96BC-4B53-8CBD-70E4F0FD780C

Q37961823-E0ED3567-7146-41C8-99B2-9C58E613349D

P2860

Q37961823-03491EF9-9D1B-4B6C-A7F0-080312AC7732

Q37961823-051DC630-C87B-484A-9AC9-2CD001A40B62

Q37961823-0BB53486-A7DC-4465-AA79-B29DBE6FF181

Q37961823-0D86066C-971C-4627-A2F1-AE75CE09F2CF

Q37961823-201C0053-FAA5-48A2-A252-E9106DD6CDD8

Q37961823-23BC47E1-F4B9-4AAF-8857-88CE6663450D

Q37961823-2863E0CB-1D5E-47CF-BAB2-A860E9A71686

Q37961823-2C642BAD-A826-47A7-957D-2DE02179B6E3

Q37961823-2EFE8549-4766-45D6-9FB2-EF0482FCA3D4

Q37961823-32CE6151-3915-4EA1-9381-21789F7FE2C6

P304

Q37961823-2FE5C0B1-6F76-4D42-8EA9-3D57A5146F9C

P31

Q37961823-63034EE5-10D6-4E3A-9C63-26AFA34BC760

P356

Q37961823-E352E732-D39D-4067-8D8E-F4B247DAA912

P407

Q37961823-6B3CB943-E984-4B72-91B0-E85E2D4B5C85

P433

Q37961823-29CF09C9-A880-4E8C-90BE-34D39B3D25DA

P478

Q37961823-3E6D5753-4FE9-4513-A417-B4504BF917B8

P50

Q37961823-2D100CFA-DB65-4694-82C8-B98F7A424F0C

Q37961823-E9AC3B74-FAA6-4669-80BD-46FF6F96CA0E

P577

Q37961823-11272BBA-1499-442C-90A8-DBC6789A1052

P698

Q37961823-49741FBD-949A-4344-A422-320463213E5D

P921

Q37961823-93F48BC8-C1FA-4EED-88C8-12C62E7B9A0D

Q37961823-B6AB0E2D-118B-4E1D-B824-AEA0C5451739

P356

PHCO.31.12.1161

P1433

Pharmacotherapy

P1476

Anticoagulation patient self-m ...... for clinical practice adoption

@en

P2093

Edith A Nutescu

http://www.w3.org/2001/XMLSchema#string

Glen T Schumock

http://www.w3.org/2001/XMLSchema#string

Marian L Fitzgibbon

http://www.w3.org/2001/XMLSchema#string

Sacheeta Bathija

http://www.w3.org/2001/XMLSchema#string

P2860

Social cognitive theory: an agentic perspective

Dabigatran versus warfarin in patients with atrial fibrillation

Self-efficacy: toward a unifying theory of behavioral change

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Partnerships between expert patients and physicians.

Self management of oral anticoagulation: randomised trial.

Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation.

Self-monitoring of oral anticoagulation: a systematic review and meta-analysis.

Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action.

P304

1161-1174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1592/PHCO.31.12.1161

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22122179

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation